Looking at the future of cardiac care, how can major device companies collaborate with the startup ecosystem? In this clip Chris Eso, Vice President, Global Head of Corporate and Business Development, M&A and Ventures at Medtronic, predicts that in the next 10-20 years, medical devices will be highly interconnected and data-driven. This shift marks a significant shift from traditional Medtech. Achieving this level of connectivity will require extensive collaboration between major device companies and the startup ecosystem. The full panel shares insights on fostering successful partnerships, enhancing patient care, and driving the next wave of breakthroughs in cardiac treatment and management. Tune into the full panel “Accelerating Cardiac Care Innovation: How Can Major Device Companies Collaborate with the Startup Ecosystem?” to hear more from Ken Nelson, Nate Harrington, Lisa Suennen, GCB.D, Chris Eso, and David Hochman.
LSI’s Post
More Relevant Posts
-
I love seeing these clips from LSI USA 2024. That conference went by so quickly that I missed too many terrific panels! I appreciate Chris Eso's take in this clip: “If you think about what the world looks like in 10-15-20 years from now from a medical device, it’s going to be all connected. It’s going to be all data generating. It’s going to be how you use that data to get better outcomes longer term.” This is exactly why The Shape Sensing Company is building tools to track surgical devices. Not just for navigation during procedures (which is a huge benefit), but the data associated with the navigation will inform us on what went right, what went wrong, and how to improve patient outcomes in the future. Fiber optic 3D guidance is the only technology that can provide full-length, three-dimensional device location, bending, and torque tracking for any tool used in a procedure. And we're not too far off from the future that Chris talks about being a reality. #patientoutcomes #digitalsurgery #futureofhealthcare #fiberoptics
Looking at the future of cardiac care, how can major device companies collaborate with the startup ecosystem? In this clip Chris Eso, Vice President, Global Head of Corporate and Business Development, M&A and Ventures at Medtronic, predicts that in the next 10-20 years, medical devices will be highly interconnected and data-driven. This shift marks a significant shift from traditional Medtech. Achieving this level of connectivity will require extensive collaboration between major device companies and the startup ecosystem. The full panel shares insights on fostering successful partnerships, enhancing patient care, and driving the next wave of breakthroughs in cardiac treatment and management. Tune into the full panel “Accelerating Cardiac Care Innovation: How Can Major Device Companies Collaborate with the Startup Ecosystem?” to hear more from Ken Nelson, Nate Harrington, Lisa Suennen, GCB.D, Chris Eso, and David Hochman.
-
Q4 M&A Moves: MedTech is on Fire! 🔥 With acquisitions heating up, major players are positioning for 2025. Here’s a look at some bold moves: • Boston Scientific x Cortex: Bringing in advanced mapping tech for AFib treatment, setting new standards in cardiac care. • Merit Medical Systems, Inc. x Cook Medical: Expanding cardiovascular capabilities through lead management solutions. • Johnson & Johnson x V-Wave: Reinforcing its structural heart portfolio with innovative interatrial shunt tech. • Hologic, Inc. x Gynesonics, Inc.: Transforming women’s health with new, minimally invasive fibroid treatments. With more deals expected before year’s end, it’s clear: MedTech leaders are betting big on strategic growth and innovation. Which acquisition stands out to you?
-
-
Manager, West Coast Account Management | Private Equity, Venture Capital, Mergers & Acquisitions
🚀 The PitchBook Q1 2024 Medtech Report is Here! 🚀 📈 Key Highlights: > Emerging innovations in whole-body scans & cardiac arrest devices > Company spotlights on Healthy.IO (at-home diagnostics) & Paige (AI imaging diagnostics) > Detailed company & deal analysis in the workspace and ACV + market map 💡 Takeaways: 1. Medtech deal activity rebounded to $3.3B in Q1 from $2.8B in Q4 Potential interest rate cuts may stabilize VC funding 2. FTC's decision on Boston-Axonics deal could impact future medtech acquisitions 3. Cardiovascular M&A is thriving: Potential targets include Cardiac Dimensions, R3 Vascular, and Corvia Medical 4. Opportunity for expansion in general diagnostic MRI screening Innovations in predicting out-of-hospital cardiac events could improve survival rates #Medtech #Innovation #VCFunding #Healthcare #M&A #Diagnostics #Cardiovascular #MRI #CardiacArrest
-
Our Swedish radiology portfolio company Collective Minds feature at #26 on Sifted’s Top 75 fastest growing startups in the Nordics & Benelux region 🎉 And what a perfect time celebrate as it's Radiological Society of North America (RSNA) week (worlds largest Radiology conference) in Chicago this week! Founded in Stockholm, Sweden in 2017, healthtech startup Collective Minds is a global, collaborative platform connecting healthcare professionals worldwide 🇸🇪 In a world where people are more connected than ever, Collective Minds has created a solution where doctors can discuss patient cases online in a safe, confidential & secure online platform 📲 Collective Minds’ CTO, Pär Kragsterman, notes that the “platform transcends simple image sharing, creating an interactive environment where radiologists can engage in real-time collaboration [and] access global expertise.” 💬 This digital revolution makes remote diagnostic services more accessible, supporting clinicians in rural healthcare facilities or medics who need an immediate expert opinion in an emergency 🏥 We first backed Collective Minds in 2020 and have continued to support them with capital over the years. We at Crista Galli Ventures are proud to see them featured on Sifted’s Leaderboard of fastest growing startups in the region 📈 #Healthtech #Healthcare #Radiology #CollectiveMinds #CMRAD
-
Director of Electrophysiology | Wharton School of Finance/ University of Pennsylvania | Private Equity Consultant | Assistant Professor | Board Advisor | MedTech Founder | TAMPA2 MAZE cofounder
The J.P. Morgan Healthcare conference and networking events (shout out to The Wharton School Healthcare night) in #SanFrancisco were incredibly impactful. Of particular relevance were discussions around emerging #meddevice and #biopharma startups, reports on recent #cardiovascular devices driving tremendous value for large strategics, and most importantly #innovation that will impact patients and their well being. #JPM25 #JPM2025 #JPMWeek #medtech #CV #healthcare #healthinnovation
-
🌟 Weekly Recap: A Week of Collaboration, and Celebration! 🌟 Last week was packed with exciting moments for NLC with HLTH, an exclusive networking dinner, successful ortho/spine panel and a festive venture day. Here's a look back at everything we had done: June 17-20: HLTH Europe We had an incredible time showcasing our health innovations at HLTH Europe. Throughout the week NLC pavilion was filled with inspiring discussions, valuable insights from venture CEOs, and a deep dive into cardiovascular, biotech, ortho/spine and general health tech solutions. It was a fantastic opportunity to connect with industry leaders and explore collaborative opportunities. June 18: Exclusive Networking Dinner We also hosted an exclusive dinner, bringing together decision-makers from the biotech, cardiovascular, ortho-spine, and general health industries. The evening was filled with enriching conversations, networking and great food. June 19: Ortho & Spine Expert Panel Besides growing our community and network, we have also engaged in meaningful discussion with professionals from our Ortho & Spine Expert Panel on technologies currently in our venture creation pipeline. We also invited three of our ventures to share their questions with the experts, as challenges and questions will continue to arise even after the venture is established. June 21: Venture Day Wrapping up the week, we hosted the annual Venture Day, uniting NLC’s ventures from around the globe. We covered critical topics such as early-stage funding, clinical trials, market access, and more. The event concluded with a graduation ceremony celebrating the achievements of Mitracept , Aerion Bioscience, ChARM, and Neurolieve Biosciences Ltd. Here's to many more fruitful weeks ahead, and cheers to transforming healthcare! 🚀 #HealthcareInnovation #HLTHEurope #VentureDay #Networking #Healthtech #Medtech #Biotech #Cardiovascular #OrthoSpine #PanelDiscussion
-
🚨 Big News in Medical Tech 🚨 Route 92 Medical, a neurovascular interventional solutions company based in San Mateo, just raised $50M in Series F extension funding! 💰 Led by Novo Holdings, the round also included US Venture Partners, Norwest Venture Partners, InnovaHealth Partners, LP, and The Vertical Group. 🏦 In connection with the investment, Noel Jee, Partner, Growth Investments, Novo Holdings US, joins the Route 92 Board of Directors. 🎯 What’s Next? The funding will accelerate global commercialization of their neurovascular intervention portfolio and support regulatory approvals in new regions. 🌍 Why it Matters: With innovations like the FreeClimb, HiPoint Catheter Systems, and the Monopoint® Operating Platform—powered by the Tenzing® Delivery Catheter—Route 92 is simplifying stroke treatment by streamlining procedures, reducing time and cost, and improving outcomes. ⏱️💡 CEO Tony Chou emphasizes how this investment will help Route 92 continue collaborating with neurovascular clinicians to solve real-world challenges and deliver differentiated solutions for better patient care. 🏥 Noel Jee, Partner at Novo Holdings, joins the Board of Directors to further drive this mission forward. 📈 💼 Transforming neuro intervention, one innovation at a time! 📢 Stay tuned to Future Techly for the latest updates on this groundbreaking initiative and the latest in tech and business! 💥 Source: FinSMEs #MedicalTech #Neurovascular #Funding #Innovation #Healthcare #Route92 #PatientCare #FutureTechly
-
-
Helsingborg-based Acorai, a company specializing in heart failure management devices, has secured €4.2 million ($4.5 million USD) in new funding. The investment, led by the European Innovation Council and SMEs Executive Agency (EISMEA), Taiwan Medical University, and private investors, will support the completion of clinical studies and regulatory approvals in the US and Europe. 𝗥𝗘𝗔𝗗 𝗧𝗛𝗘 𝗗𝗘𝗧𝗔𝗜𝗟𝗦 👉 https://lnkd.in/dWknxTaz Filip Peters Jing Wei Luo (羅敬為) Matthew Mace Patrick NJ Schnegelsberg Sitt Nyein Chan Jakob Gelberg Lance Myers Anissa Selmani Anna Rydén Johannes Gladisch Cosmin Stamate Kasper Bourdette Parth Patel MD #startups #founders #fundingnews #venturecapital #privateequity #monitoring #investments #investors #medtech
-
Is your head spinning from all the #technology sectors I talk about? If not (yet), check out my recent thought leadership article on #MedTech and its business models. One of my favourite industries ever🤘 #strategic #businessmodel #innovation
Excited to share our latest thought leadership article, "Scotland, at the Forefront of MedTech Innovation" 🌟 In this piece, our consultant Jolanta Beinaroviča, PhD looks into how Scotland's pioneering advancements, robust support structures, and innovative business models create a dynamic ecosystem to lead the MedTech industry. Medical Device Manufacturing Centre Digital Health & Care Innovation Centre #MedTech #HealthcareInnovation #ThoughtLeadership #MedicalTechnology #Innovation #Healthcare #TechAdvancement #FutureOfHealthcare #Networking https://lnkd.in/eS_Abuaq
Expert in TechMed StartUps and Surgical Robotics. And F'in good at it. AI digital health endovascular robotics neurovascular robotics cardiac robotics future of healthcare. NED Board Advisor Investor linked Influencer
9moMy question is - do we need to replace a lot of people in the big strategics? You know the old school suit wearing ones that are analogue born n raised. The ones that are not digitally native. They struggle to deal with email and don't understand the reality of true digital marketing? The "rep to clinician" sell brigade that can't understand how hard and complex these sales will be in the future. The end of career group that think "If I just say No enough and don't make any risky decisions... I won't get fired from my big salary - car and upcoming pension pot." Because this next generation of products - ecosystems, AI - interlinked complexity - fast spin cycles - disruptive models are going to fail fast unless you have the right mindset and experience of leaders behind it. Digitally native health care people are few and far between. You can only go and poach so many from Intuitive